Sign in
Taking people in United StatesNo phase

Assessing the Relationship Between Symptoms and Mitral Regurgitnant. Severity

Key facts

Who runs it
Atlantic Health System
Where
Morristown, United StatesSee the site
Trial code
Status
Recruiting
People taking part
40 people, planned
Started
2 Jan 2025
Expected to end
2 May 2027
Type of study
Observational
Treatments tested
  • Pressure volume loop evaluation
  • cardiovascular magnetic resonance imaging
  • Cardiopulmonary exercise testing (CPET)
  • Kansas City Cardiomyopathy Questionairre
Record updated
17 December 2024

Who can take part

Age
18 years and older
Sex
Men only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age >=18 years of age
  • Able to give informed consent
  • Primary (degenerative) mitral regurgitation
  • LVEF >=50%
  • Undergoing cardiac catheterization
  • Able to exercise on a treadmill

Who cannot take part

  • LVEF <50%
  • Unable to give informed consent
  • Secondary (functional) mitral regurgitation
  • Known coronary artery stenosis >=70% or past revascularization
  • More than mild aortic stenosis, mitral stenosis, aortic regurgitation, tricuspid regurgitation, or pulmonic regurgitation
  • Hypertrophic cardiomyopathy
  • Pregnancy

Where in United States

  • Morristown Medical CenterMorristown, United StatesContact: Kush Murkerjee, MATaking people

About the trial

What the trial wants to find out

The current American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend surgery in patient with mitral regurgitation (MR) based on 1) the severity of MR and 2) the presence or absence of symptoms. Studies have shown that Cardiovascular Magnetic Resonance (CMR) is an accurate method to quantify the severity of MR. However, studies have also shown that symptoms are not necessarily related to the presence of symptoms. Thus, there appears to be a disconnect between the severity of MR and symptoms. Recent analysis of our data has shown that females and older patients with smaller ventricles, lower stroke volumes, and lower regurgitant volume relative to regurgitant fraction tend to be symptomatic. These findings suggest that decreased left ventricular compliance, i.e. diastolic dysfunction, may play an important role as an etiology of symptoms in patients with mitral regurgitation. The aim of this study is to study the presence of diastolic dysfunction in patients with MR and its association with symptom burden and exercise capacity.

The group in the trial

  • Mitral Regurgitation

    Patients with mitral regurgitation undergoing a left heart catheterization prior to mitral valve surgery or mitral valve clip.

    Treatment: Pressure volume loop evaluation, cardiovascular magnetic resonance imaging, Cardiopulmonary exercise testing (CPET), and Kansas City Cardiomyopathy Questionairre

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Assessing the Impact of Diastolic Dysfunction on the Presence of Symptoms in Patients with Primary Mitral Regurgitation.
Record updated
17 December 2024